CAICaris Life Sciences Inc.
Slide 1 of 3
Company Overview
Name
Caris Life Sciences Inc.
52W High
$42.50
52W Low
$22.86
Market Cap
$7.1B
Dividend Yield
0%
Price/earnings
0.09
P/E
0.09
Tags
Dividends
No dividend
Sentiment
Score
Bullish
67
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$216.8M
Operating Revenue
$216.8M
Total Gross Profit
$147.5M
Total Operating Income
$32.6M
Net Income
$24.3M
EV to EBITDA
$0.00
EV to Revenue
$0.00
Price to Book value
$0.00
Price to Earnings
$0.00
Additional Data
Selling, General & Admin Expense
$52M
Marketing Expense
$41.3M
Research & Development Expense
$21.6M
Total Operating Expenses
$-114.9M
Interest Expense
$-13.5M
Interest & Investment Income
$7.4M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Caris Life Sciences Inc.
52W High
$42.50
52W Low
$22.86
Market Cap
$7.1B
Dividend Yield
0%
Price/earnings
0.09
P/E
0.09
Tags
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Bullish
67
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$216.8M
Operating Revenue
$216.8M
Total Gross Profit
$147.5M
Total Operating Income
$32.6M
Net Income
$24.3M
EV to EBITDA
$0.00
EV to Revenue
$0.00
Price to Book value
$0.00
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$52M
Marketing Expense
$41.3M
Research & Development Expense
$21.6M
Total Operating Expenses
$-114.9M
Interest Expense
$-13.5M
Interest & Investment Income
$7.4M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
David D. Halbert
Location
TX, USA
Exchange
Nasdaq
Website
https://www.carislifesciences.com
Summary
We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer.
Company Info
CEO
David D. Halbert
Location
TX, USA
Exchange
Nasdaq
Website
https://www.carislifesciences.com
Summary
We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer.
